Enterome
Clinical trials sponsored by Enterome, explained in plain language.
-
Cancer vaccine combo trial halted after enrolling just one patient
Disease control TerminatedThis study tested a new vaccine (EO2040) made from gut bacteria, combined with the immunotherapy drug nivolumab, in people with colorectal cancer who had signs of remaining disease after standard treatment. The goal was to see if the combination could clear cancer DNA from the bl…
Phase: PHASE2 • Sponsor: Enterome • Aim: Disease control
Last updated May 17, 2026 05:46 UTC
-
Experimental vaccine tackles rare adrenal cancers
Disease control TerminatedThis study tested a new therapeutic vaccine (EO2401) combined with immune checkpoint blockers in 70 people with advanced adrenal cancers (adrenocortical carcinoma or malignant pheochromocytoma/paraganglioma). The goal was to see if the vaccine could help the immune system fight t…
Phase: PHASE1, PHASE2 • Sponsor: Enterome • Aim: Disease control
Last updated May 13, 2026 16:00 UTC